Corvite 150 By Vertical Pharmaceuticals Overview & Drug Interactions

Check For Interactions With Corvite 150

Supplement: Corvite 150 by Vertical Pharmaceuticals

Corvite 150 Label Images

This product contains

Below is a list of the 'active' ingredients listed on the supplement label for this product.

For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.

Drugs that interact with Corvite 150 by Vertical Pharmaceuticals

Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.

Label Information

Supplement Facts:

Daily Value (DV) Target Group(s): Adults and children 4 or more years of age
Minimum serving Sizes:
1 Tablet(s)
Maximum serving Sizes:
1 Tablet(s)
Servings per container 30
UPC/BARCODE 368025-052-306

Ingredient Amount per Serving Group % DV, Adults & children 4+ years
Vitamin C
120 mg
Vitamin C 200%
Calcium Threonate
5 mg
Calcium 0.5%
Vitamin B6
10 mg
Vitamin B6 500%
Vitamin B7
100 mcg
Biotin 33%
Vitamin B12
20 mcg
Vitamin B12 333%
Folate
1 mg
Folate 250%
Folic Acid
700 mcg
Folate
Quatrefolic
300 mcg
5-methyltetrahydrofolate glucosamine
Iron
150 mg
Iron 833%
Magnesium
10 mg
Magnesium 3%
Zinc
25 mg
Zinc 167%

Other Ingredients:
Microcrystalline Cellulose
Starch, Pregelatinized
Dicalcium Phosphate
Hydroxypropylmethylcellulose
Polyvinyl alcohol
FD&C Red #40 Lake
Polyethylene Glycol
Talc
Titanium Dioxide
Croscarmellose Sodium
Stearic Acid
Magnesium Stearate


Label Statments:


General Statements
- 68025-052-30 Rx only
- Description: Corvite 150 are red, oval bisected tablets embossed "VP052." How Supplied: Corvite 150 tablets are supplied in bottles of 30 units.
- Lift here for full product information
Formula
- Now with Quatrefolic
- Iron Supplementation
- Clinical Pharmacology: Iron is an essential component in the formation of hemoglobin. Adequate amounts of iron are necessary for effective erythropoiesis. Iron also serves as a cofactor of several essential enzymes, including cytochromes that are involved in electron transport. Folic acid is required for nucleoprotein synthesis and the maintenance of normal erythropoiesis. Folic acid is converted in the liver and plasma to its metabolically active form, tetrahydrofolic acid, by dihydrofolate reductase. Vitamin B12 is required for the maintenance of normal erythropoiesis, nucleoprotein and myelin synthesis, cell reproduction and normal growth. Intrinsic factor, a glycoprotein secreted by the gastric mucosa, is required for active absorption of vitamin B12 from the gastrointestinal tract.
Brand IP Statement(s)
- Patent pending
- Quatrefolic is a registered trademark of Gnosis, SpA. -U.S. Patent No. 7,947,662.
Formulation
- Sugar, lactose & gluten free
- Vegan safe
- Indications and Usage: Corvite 150 is indicated for the prevention and treatment of iron deficiency anemia and/or nutritional megaloblastic anemias.
Suggested/Recommended/Usage/Directions
- Dosage & Administration Usual adult dose is 1 tablet daily, or as directed by a physician.
Storage
- Storage Store at controlled room temperature 15 degrees-30 degrees C (59 degrees-86 degrees F) [see USP]. Protect from light and moisture and avoid excessive heat. Dispense in a tight, light resistant container as defined by the USP using a child-resistant closure.
Precautions
- Warning: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.
- Contraindications: Corvite 150 is contraindicated in patients with a known hypersensitivity to any of the components of this product. Hemochromatosis and hemosiderosis are contraindications to iron therapy. Warnings: Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin b12 is deficient. Precautions General: Do not exceed recommended dose. The type of anemia and the underlying cause or causes should be determined before starting therapy with Corvite 150. Since the anemia may be a result of a systemic disturbance, such as recurrent blood loss, the underlying cause or causes should be corrected, if possible. Folic Acid: Folic acid in doses above 0.1 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations remain progressive. Pernicious anemia should be excluded before using this product since folic acid may mask the symptoms of pernicious anemia
- Pediatric Use: Safety and effectiveness in pediatric patients have not been established.
- Geriatric Use: Clinical studies on this product have not been performed in subjects aged 65 and over to determine whether elderly subjects respond differently from younger subjects. In general, dose selection for an elderly patient should be cautious. Adverse Reactions: Adverse reactions with iron therapy may include constipation, diarrhea, nausea, vomiting, dark stools and abdominal pain. Adverse reactions with iron therapy are usually transient.
- Allergic sensitization has been reported following both oral and parenteral administration of folic acid.
- Overdosage: The clinical course of acute iron overdosage can be variable. Initial symptoms may include abdominal pain, nausea, vomiting, diarrhea, tarry stools melena, hematemesis, hypotension, tachycardia, metabolic acidosis, hyperglycemia, dehydration, drowsiness, pallor, cyanosis, lassitude, seizures, shock and coma.
- Keep out of the reach of children.
- Call your doctor about side effects.

Brand Information

See all products by this brand

Manufactured for
Name Vertical Pharmaceuticals, Inc.
City Sayreville
State NJ
ZipCode 08872
Web Address www.verticalpharma.com
You may report side effects by calling
Phone Number 1-877-958-3784

Return to the main supplement interaction checker page

Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Drug descriptions are provided by MedlinePlus.